Department of Physiology, University of Melbourne, Parkville, Victoria, Australia; and.
Am J Physiol Gastrointest Liver Physiol. 2014 May 1;306(9):G748-58. doi: 10.1152/ajpgi.00416.2013. Epub 2014 Feb 27.
In the gastrointestinal tract, vasoactive intestinal peptide (VIP) is found exclusively within neurons. VIP regulates intestinal motility via neurally mediated and direct actions on smooth muscle and secretion by a direct mucosal action, and via actions on submucosal neurons. VIP acts via VPAC1 and VPAC2 receptors; however, the subtype involved in its neural actions is unclear. The neural roles of VIP and VPAC1 receptors (VPAC1R) were investigated in intestinal motility and secretion in guinea pig jejunum. Expression of VIP receptors across the jejunal layers was examined using RT-PCR. Submucosal and myenteric neurons expressing VIP receptor subtype VPAC1 and/or various neurochemical markers were identified immunohistochemically. Isotonic muscle contraction was measured in longitudinal muscle-myenteric plexus preparations. Electrogenic secretion across mucosa-submucosa preparations was measured in Ussing chambers by monitoring short-circuit current. Calretinin(+) excitatory longitudinal muscle motor neurons expressed VPAC1R. Most cholinergic submucosal neurons, notably NPY(+) secretomotor neurons, expressed VPAC1R. VIP (100 nM) induced longitudinal muscle contraction that was inhibited by TTX (1 μM), PG97-269 (VPAC1 antagonist; 1 μM), and hyoscine (10 μM), but not by hexamethonium (200 μM). VIP (50 nM)-evoked secretion was depressed by hyoscine or PG97-269 and involved a small TTX-sensitive component. PG97-269 and TTX combined did not further depress the VIP response observed in the presence of PG97-269 alone. We conclude that VIP stimulates ACh-mediated longitudinal muscle contraction via VPAC1R on cholinergic motor neurons. VIP induces Cl(-) secretion directly via epithelial VPAC1R and indirectly via VPAC1R on cholinergic secretomotor neurons. No evidence was obtained for involvement of other neural VIP receptors.
在胃肠道中,血管活性肠肽 (VIP) 仅存在于神经元中。VIP 通过神经介导和对平滑肌的直接作用以及通过直接粘膜作用对分泌的直接作用来调节肠道运动,并通过对粘膜下神经元的作用来调节。VIP 通过 VPAC1 和 VPAC2 受体起作用;然而,其神经作用涉及的亚型尚不清楚。本研究旨在研究 VIP 和 VPAC1 受体 (VPAC1R) 在豚鼠空肠运动和分泌中的神经作用。使用 RT-PCR 检查 VIP 受体在空肠各层中的表达。免疫组织化学法鉴定表达 VIP 受体亚型 VPAC1 和/或各种神经化学标志物的粘膜下和肌间神经元。在纵向肌-肌间神经丛制剂中测量等张肌肉收缩。通过监测短路电流,在 Ussing 室中测量粘膜-粘膜下制剂的电分泌。Calretinin(+) 兴奋性纵向肌运动神经元表达 VPAC1R。大多数胆碱能粘膜下神经元,特别是 NPY(+) 分泌运动神经元,表达 VPAC1R。VIP(100 nM)诱导纵向肌肉收缩,该收缩被 TTX(1 μM)、PG97-269(VPAC1 拮抗剂;1 μM)和氢溴酸东莨菪碱(10 μM)抑制,但不受六烃季铵(200 μM)抑制。VIP(50 nM)诱导的分泌被氢溴酸东莨菪碱或 PG97-269 抑制,涉及小的 TTX 敏感成分。PG97-269 和 TTX 联合使用不会进一步抑制单独使用 PG97-269 时观察到的 VIP 反应。我们的结论是,VIP 通过胆碱能运动神经元上的 VPAC1R 刺激 ACh 介导的纵向肌肉收缩。VIP 通过上皮细胞 VPAC1R 直接诱导 Cl(-)分泌,并通过胆碱能分泌运动神经元上的 VPAC1R 间接诱导 Cl(-)分泌。没有证据表明涉及其他神经 VIP 受体。